Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension

SONG Jiemei; WEN Xiaoan; SUN Hongbin

doi:10.11665/j.issn.1000-5048.20130101

SONG Jiemei, WEN Xiaoan, SUN Hongbin. Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension[J]. Journal of China Pharmaceutical University, 2013, 44(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20130101

Citation:

SONG Jiemei, WEN Xiaoan, SUN Hongbin. Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension[J]. Journal of China Pharmaceutical University, 2013, 44(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20130101

Citation:

SONG Jiemei, WEN Xiaoan, SUN Hongbin. Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension[J]. Journal of China Pharmaceutical University, 2013, 44(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20130101

Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension

Graphical Abstract

Graphical Abstract

Abstract

Abstract

Pulmonary arterial hypertension(PAH) is a progressive and fatal disease,characterized by elevated pulmonary vascular resistance and pulmonary arterial pressure,most often resulting in right-sided heart failure.The mechanisms of action,approved PAH therapies and the latest agents in late-stage clinical development were reviewed and described in this paper.

FullText(HTML)

References (0)

Progress in pathogenesis and therapeutic drugs of pulmonary arterial hypertension

Graphical Abstract

Abstract

Catalog

Export File

Citation

Format

Content